Table 6. Significant prognostic factors on univariate analysis for PFS.

		Median	0.95LCL–0.95UCL	p	HR	0.95LCL–0.95UCL
TKI used in 1L line of therapy	No	5.78	3.42–12	0.0001
	Yes	27.07	24.28–NA		0.2047	0.1084–0.3866
ECOG PS at presentation	0–2	17.05	11.96–35.1	0.0001
	3–4	1.94	0.49–NA		4.323	2.032–9.197
Serum albumin at presentation	≤3.9 g/dL	11.9	6.87–24.5	0.044
	>3.9 g/dL				2.327	1–5.414
Serum alkaline phospahatase	≤109 U/L	24.28	17.05–NA	0.0026
	>109 U/L	9.92	6.37–24.5		2.669	1.377–5.174